These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 415061)

  • 1. Cultivation of dengue virus type 2 in candidate substrates for vaccine production.
    Dubois DR; Berman S; Rourke SM; Timchak RL; Lowenthal JP
    J Biol Stand; 1978 Jan; 6(1):21-6. PubMed ID: 415061
    [No Abstract]   [Full Text] [Related]  

  • 2. Selection of attenuated dengue 4 viruses by serial passage in primary kidney cells. IV. Characterization of a vaccine candidate in fetal rhesus lung cells.
    Halstead SB; Eckels KH; Putvatana R; Larsen LK; Marchette NJ
    Am J Trop Med Hyg; 1984 Jul; 33(4):679-83. PubMed ID: 6476215
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Selection of attenuated dengue 4 viruses by serial passage in primary kidney cells. I. Attributes of uncloned virus at different passage levels.
    Halstead SB; Diwan AR; Marchette NJ; Palumbo NE; Srisukonth L
    Am J Trop Med Hyg; 1984 Jul; 33(4):654-65. PubMed ID: 6476212
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Modification of dengue virus strains by passage in primary dog kidney cells: preparation of candidate vaccines and immunization of monkeys.
    Eckels KH; Dubois DR; Putnak R; Vaughn DW; Innis BL; Henchal EA; Hoke CH
    Am J Trop Med Hyg; 2003 Dec; 69(6 Suppl):12-6. PubMed ID: 14740950
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tick-borne Langat/mosquito-borne dengue flavivirus chimera, a candidate live attenuated vaccine for protection against disease caused by members of the tick-borne encephalitis virus complex: evaluation in rhesus monkeys and in mosquitoes.
    Pletnev AG; Bray M; Hanley KA; Speicher J; Elkins R
    J Virol; 2001 Sep; 75(17):8259-67. PubMed ID: 11483771
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Introduction of mutations into the non-structural genes or 3' untranslated region of an attenuated dengue virus type 4 vaccine candidate further decreases replication in rhesus monkeys while retaining protective immunity.
    Hanley KA; Manlucu LR; Manipon GG; Hanson CT; Whitehead SS; Murphy BR; Blaney JE
    Vaccine; 2004 Sep; 22(25-26):3440-8. PubMed ID: 15308370
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Virulence of a live dengue virus vaccine candidate: a possible new marker of dengue virus attenuation.
    Innis BL; Eckels KH; Kraiselburd E; Dubois DR; Meadors GF; Gubler DJ; Burke DS; Bancroft WH
    J Infect Dis; 1988 Oct; 158(4):876-80. PubMed ID: 3171230
    [No Abstract]   [Full Text] [Related]  

  • 8. Subhuman primate diploid cells: possible substrates for production of virus vaccines.
    Petricciani JC; Hopps HE; Lorenz DE
    Science; 1971 Dec; 174(4013):1025-7. PubMed ID: 5000950
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A single amino acid substitution in the envelope protein of chimeric yellow fever-dengue 1 vaccine virus reduces neurovirulence for suckling mice and viremia/viscerotropism for monkeys.
    Guirakhoo F; Zhang Z; Myers G; Johnson BW; Pugachev K; Nichols R; Brown N; Levenbook I; Draper K; Cyrek S; Lang J; Fournier C; Barrere B; Delagrave S; Monath TP
    J Virol; 2004 Sep; 78(18):9998-10008. PubMed ID: 15331733
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nonhuman primate diploid cells for vaccine production.
    Petricciani JC
    Dev Biol Stand; 1976 Dec 13-15; 37():21-5. PubMed ID: 1036399
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rapid titration of dengue virus type 4 infectivity by counting fluorescent foci.
    Igarashi A; Mantani M
    Biken J; 1974 Sep; 17(3):87-93. PubMed ID: 4218091
    [No Abstract]   [Full Text] [Related]  

  • 12. [Use of diploid cell lines as a multiplication substrate for viral vaccine production].
    Welke G
    Z Gesamte Hyg; 1980; 26(5):365-72. PubMed ID: 7008390
    [No Abstract]   [Full Text] [Related]  

  • 13. Mosquito and mammalian cells grown on microcarriers for four-serotype dengue virus production: variations in virus titer, plaque morphology, and replication rate.
    Liu CC; Wu SC
    Biotechnol Bioeng; 2004 Mar; 85(5):482-8. PubMed ID: 14760688
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tests for RNA tumor viruses in cell substrates used in virus vaccine production.
    Petricciani JC; Milstien JB
    Dev Biol Stand; 1976 Dec 13-15; 37():229-34. PubMed ID: 73485
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Selection of attenuated dengue 4 viruses by serial passage in primary kidney cells. V. Human response to immunization with a candidate vaccine prepared in fetal rhesus lung cells.
    Eckels KH; Scott RM; Bancroft WH; Brown J; Dubois DR; Summers PL; Russell PK; Halstead SB
    Am J Trop Med Hyg; 1984 Jul; 33(4):684-9. PubMed ID: 6476216
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vaccine candidates derived from a novel infectious cDNA clone of an American genotype dengue virus type 2.
    Blaney JE; Hanson CT; Hanley KA; Murphy BR; Whitehead SS
    BMC Infect Dis; 2004 Oct; 4():39. PubMed ID: 15461822
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Primary isolation and phylogenetic studies of Chikungunya virus from Surabaya, Indonesia.
    Mulyatno KC; Susilowati H; Yamanaka A; Soegijanto S; Konishi E
    Jpn J Infect Dis; 2012; 65(1):92-4. PubMed ID: 22274167
    [No Abstract]   [Full Text] [Related]  

  • 18. Pathogenesis and immunity of dengue infection in man.
    Hotta S
    Kobe J Med Sci; 1972 Dec; 18(4):199-210. PubMed ID: 4200060
    [No Abstract]   [Full Text] [Related]  

  • 19. Development of a purified, inactivated, dengue-2 virus vaccine prototype in Vero cells: immunogenicity and protection in mice and rhesus monkeys.
    Putnak R; Barvir DA; Burrous JM; Dubois DR; D'Andrea VM; Hoke CH; Sadoff JC; Eckels KH
    J Infect Dis; 1996 Dec; 174(6):1176-84. PubMed ID: 8940206
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recombinant chimeric yellow fever-dengue type 2 virus is immunogenic and protective in nonhuman primates.
    Guirakhoo F; Weltzin R; Chambers TJ; Zhang ZX; Soike K; Ratterree M; Arroyo J; Georgakopoulos K; Catalan J; Monath TP
    J Virol; 2000 Jun; 74(12):5477-85. PubMed ID: 10823852
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.